Outcomes in human immunodeficiency virus-infected pregnant women treated with protease inhibitors

被引：0
|
作者：
Einstein, FH [1 ]
Wright, R [1 ]
Trentacoste, S [1 ]
Chazotte, C [1 ]
Merkatz, IR [1 ]
Bernstein, PS [1 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
OBSTETRICS AND GYNECOLOGY | 2004年 / 103卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：24S / 24S
页数：1
相关论文
共 50 条
  • [1] Risk of Preeclampsia in Human Immunodeficiency Virus-Infected Pregnant Women
    Sansone, Matilde
    Sarno, Laura
    Saccone, Gabriele
    Berghella, Vincenzo
    Maruotti, Giuseppe Maria
    Migliucci, Annalisa
    Capone, Angela
    Martinelli, Pasquale
    [J]. OBSTETRICS AND GYNECOLOGY, 2016, 127 (06): : 1027 - 1032
  • [2] A retrospective analysis of adverse perinatal outcomes in human immunodeficiency virus-infected pregnant women
    Burke, Charlotte V.
    Tuuli, Methodius
    Basanta-Henry, Patrice
    Duong, Ninh
    Linay, Michael
    [J]. OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 80S - 80S
  • [3] Early experience with protease inhibitors in human immunodeficiency virus-infected children
    Sáez-Llorens, X
    Ramilo, O
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (08) : 728 - 738
  • [4] Safety and Efficacy of Fosamprenavir in Human Immunodeficiency Virus-infected Pregnant Women
    Martorell, Claudia
    Theroux, Eileen
    Bermudez, Arlene
    Garb, Jane
    Kronschnabel, Debra
    Oie, Katrina
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (10) : 985 - 985
  • [5] TREATMENT OPTIONS FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PREGNANT-WOMEN
    SPERLING, RS
    STRATTON, P
    [J]. OBSTETRICS AND GYNECOLOGY, 1992, 79 (03): : 443 - 448
  • [6] Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women
    Unadkat, Jashvant D.
    Wara, Diane W.
    Hughes, Michael D.
    Mathias, Anita A.
    Holland, Diane T.
    Paul, Mary E.
    Connor, James
    Huang, Sharon
    Nguyen, Bach-Yen
    Watts, D. Heather
    Mofenson, Lynne M.
    Smith, Elizabeth
    Deutsch, Paul
    Kaiser, Kathleen A.
    Tuomala, Ruth E.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) : 783 - 786
  • [7] Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women
    McGowan, JP
    Crane, M
    Wiznia, AA
    Blum, S
    [J]. OBSTETRICS AND GYNECOLOGY, 1999, 94 (05): : 641 - 646
  • [8] Codon 215 mutations in human immunodeficiency virus-infected pregnant women
    Kully, C
    Yerly, S
    Erb, P
    Kind, C
    Krautheim, A
    Perrin, L
    Rudin, C
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (03): : 705 - 708
  • [9] Abnormalities in plasma fatty acid composition in human immunodeficiency virus-infected children treated with protease inhibitors
    Aldámiz-Echevarría, L
    Pocheville, I
    Sanjurjo, P
    Elorz, J
    Prieto, JA
    Rodríguez-Soriano, J
    [J]. ACTA PAEDIATRICA, 2005, 94 (06): : 672 - 677
  • [10] Insulin resistance complicating pregnancy in a human immunodeficiency virus-infected patient treated with protease inhibitors and corticosteroids
    Aschkenazi, S
    Rochelson, B
    Bernasko, J
    Kaplan, J
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 102 (05): : 1210 - 1212
12345